A disciplined, milestone-driven layout. Early discovery, validation, and patent protections have been successfully completed through targeted self-funding.
From early-stage target discovery to first-in-class therapeutics, our portfolio spans the critical milestones in CEF research. Each project reflects our commitment to restoring precise gene expression in cells where regulatory control has been compromised, advancing translational science toward measurable patient outcomes.